Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Weight Gain × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Other 2 Lymphoid 1 Genitourinary 1 Gastrointestinal 1 Endocrine 1

Conditions

Prostatic Neoplasms 3971 Urinary Bladder Neoplasms 956 Carcinoma, Renal Cell 918 Kidney Neoplasms 502 Breast Neoplasms 408 Neoplasms 356 Carcinoma, Transitional Cell 255 Neoplasm Metastasis 220 Lung Neoplasms 216 Testicular Neoplasms 174 Melanoma 174 Colorectal Neoplasms 173 Ovarian Neoplasms 138 Carcinoma, Non-Small-Cell Lung 132 Sarcoma 123 Non-Muscle Invasive Bladder Neoplasms 115 Pancreatic Neoplasms 108 Colonic Neoplasms 104 Head and Neck Neoplasms 100 Wilms Tumor 99 Uterine Cervical Neoplasms 96 Recurrence 93 Motor Activity 91 Neuroblastoma 79 Multiple Myeloma 78 Stomach Neoplasms 75 Urologic Neoplasms 74 Disease 70 Adenocarcinoma 67 Esophageal Neoplasms 66

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01996696 2024-01-30

PREMIUM

AHS Cancer Control Alberta

Phase 2 Terminated

Prostatic Neoplasms, Weight Gain, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡